SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027756
Filing Date
2021-11-10
Accepted
2021-11-10 08:00:41
Documents
67
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1588490
2 ex10-1.htm EX-10.1 457964
3 ex10-2.htm EX-10.2 61167
4 ex31-1.htm EX-31.1 16286
5 ex31-2.htm EX-31.2 14897
6 ex32-1.htm EX-32.1 4680
7 ex32-2.htm EX-32.2 5007
  Complete submission text file 0001493152-21-027756.txt   6668684

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE lpcn-20210930.xsd EX-101.SCH 38596
9 XBRL CALCULATION FILE lpcn-20210930_cal.xml EX-101.CAL 47923
10 XBRL DEFINITION FILE lpcn-20210930_def.xml EX-101.DEF 180051
11 XBRL LABEL FILE lpcn-20210930_lab.xml EX-101.LAB 339066
12 XBRL PRESENTATION FILE lpcn-20210930_pre.xml EX-101.PRE 272736
13 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 951847
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 211394478
SIC: 2834 Pharmaceutical Preparations